GBS INC (GBS) Stock Price, Quote, News and Overview
NASDAQ:GBS - Nasdaq - US36151G1058 - Common Stock - Currency: USD
GBS Quote, Performance and Key Statistics
0.4732
0 (-0.04%)
The current stock price of GBS is 0.4732 USD. In the past month the price increased by 13.97%. In the past year, price decreased by -76.8%.
GBS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.2 | 233.79B | ||
| ISRG | INTUITIVE SURGICAL INC | 73.77 | 202.01B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.27 | 156.84B | ||
| SYK | STRYKER CORP | 31.46 | 150.47B | ||
| MDT | MEDTRONIC PLC | 16.19 | 110.86B | ||
| BDX | BECTON DICKINSON AND CO | 12.45 | 50.37B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30 | 45.86B | ||
| IDXX | IDEXX LABORATORIES INC | 45.45 | 41.99B | ||
| RMD | RESMED INC | 27.72 | 36.91B | ||
| DXCM | DEXCOM INC | 51.81 | 33.52B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.9 | 33.48B | ||
| STE | STERIS PLC | 26.94 | 24.72B |
Related stock screener links
About GBS
Company Profile
GBS, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2020-12-23. The Company’s products include Biosensor Platform Technology, Saliva Glucose Test (SGT) and Saliva Glucose Biosensor (SGB). The Biosensor Platform is a SGB-based modified Organic Thin Film Transistor (OTFT). The OTFT structure consists of a source and drain electrode, a semiconducting layer, a gate electrode, an optional separation (or dielectric) layer, all printed on a substrate material and superimposed by a polyelectrolyte membrane/enzyme layer onto which the analyte is placed. The SGT consists of SGB, which is a single use disposable saliva biosensor, and Software app, which is a smart device or a dedicated reader that interfaces the SGB with its digital information system. The SGB interacts with the glucose in the saliva and initiates an electrochemical reaction, producing an electrical signal directly correlated to the amount of glucose present in the saliva.
Company Info
GBS INC
142 West 57th Street, 11th Floor
New York City NEW YORK US
Employees: 12
Phone: 16462336971.0
GBS INC / GBS FAQ
What is the stock price of GBS INC today?
The current stock price of GBS is 0.4732 USD. The price decreased by -0.04% in the last trading session.
What is the ticker symbol for GBS INC stock?
The exchange symbol of GBS INC is GBS and it is listed on the Nasdaq exchange.
On which exchange is GBS stock listed?
GBS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GBS INC stock?
0 analysts have analysed GBS and the average price target is 4.59 USD. This implies a price increase of 869.99% is expected in the next year compared to the current price of 0.4732. Check the GBS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GBS INC worth?
GBS INC (GBS) has a market capitalization of 7.05M USD. This makes GBS a Nano Cap stock.
How many employees does GBS INC have?
GBS INC (GBS) currently has 12 employees.
What are the support and resistance levels for GBS INC (GBS) stock?
GBS INC (GBS) has a support level at 0.44 and a resistance level at 0.48. Check the full technical report for a detailed analysis of GBS support and resistance levels.
Is GBS INC (GBS) expected to grow?
The Revenue of GBS INC (GBS) is expected to decline by -100% in the next year. Check the estimates tab for more information on the GBS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GBS INC (GBS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GBS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GBS, evaluating the profitability, health, valuation and growth aspects
- GBS INC (GBS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GBS INC (GBS) Sales and EPS estimates to see what analysts future expectations are.
- GBS INC (GBS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GBS INC (GBS) Insider and Institutional Ownership to learn about the owners and their transactions.
- GBS INC (GBS) Stock Chart to make your own analysis
- GBS INC (GBS) Latest news and press-releases to stay up to date.
Does GBS INC (GBS) stock pay dividends?
GBS does not pay a dividend.
When does GBS INC (GBS) report earnings?
GBS INC (GBS) will report earnings on 2022-11-10, before the market open.
What is the Price/Earnings (PE) ratio of GBS INC (GBS)?
GBS INC (GBS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).
GBS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GBS. When comparing the yearly performance of all stocks, GBS is a bad performer in the overall market: 88.45% of all stocks are doing better.
GBS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GBS. GBS may be in some trouble as it scores bad on both profitability and health.
GBS Financial Highlights
Over the last trailing twelve months GBS reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 17.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1900.05% | ||
| ROA | -67.24% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
GBS Ownership and Analysts
For the next year, analysts expect an EPS growth of 44.09% and a revenue growth -100% for GBS